OpenBilldrug price receipt

NADAC week of 2026-10-14

LIPITOR 10 MG TABLET

FDA nonproprietary name: atorvastatin calcium

For 30 tablets

Pharmacies pay

$402.25 filed

30 × $13.40831 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$471.28 filed

30 × $15.7092 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.2× estimated

Medicare paid 1.2× what pharmacies pay.

Part D averages every strength and form sold under “Lipitor” / “Atorvastatin Calcium” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$467.59 estimated

$402.25 + $60.34 (15%) + $5.00 fee per fill = $467.59

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LIPITOR 10 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as atorvastatin calcium, under the trade name “Lipitor”.

FDA gives its dosage form as tablet, film coated and its route as oral.

The labeler, the company named on the label, is Viatris Specialty LLC.

FDA’s Established Pharmacologic Class for it is HMG-CoA Reductase Inhibitor.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 58151-0155-77.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $402.25 for 30 tablets (30 × $13.40831 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.02283 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

7 other products in the NADAC file share the FDA nonproprietary name atorvastatin calcium with LIPITOR 10 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ATORVASTATIN 10 MG TABLET
generic · tablet, film coated / tablet
$0.02283 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.14518 per EA filed
Part D 2024 average
ATORVASTATIN 20 MG TABLET
generic · tablet, film coated / tablet
$0.02792 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.14518 per EA filed
Part D 2024 average
ATORVASTATIN 40 MG TABLET
generic · tablet, film coated / tablet
$0.03743 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.14518 per EA filed
Part D 2024 average
ATORVASTATIN 80 MG TABLET
generic · tablet, film coated / tablet
$0.06926 per EA filed
eff. 2026-09-23 to 2026-10-07
$0.14518 per EA filed
Part D 2024 average
LIPITOR 10 MG TABLET this page
brand · tablet, film coated
$13.40831 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average
LIPITOR 20 MG TABLET
brand · tablet, film coated
$19.07256 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average
LIPITOR 40 MG TABLET
brand · tablet, film coated
$19.11383 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average
LIPITOR 80 MG TABLET
brand · tablet, film coated
$19.00394 per EA filed
eff. 2026-09-23
$15.7092 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $13.40831 per EA filed.

Of the 56 other products in FDA’s HMG-CoA Reductase Inhibitor class priced per EA, 5 have a higher middle NADAC price and 51 a lower one. The one in the middle is PITAVASTATIN 2 MG TABLET, at $0.95425 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $471.28 for 30 tablets, at an average of $15.7092 per EA in 2024 (2024-01-01 to 2024-12-31) for “Lipitor” and “Atorvastatin Calcium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 23,269 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for LIPITOR 10 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Lipitor / Atorvastatin Calcium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.